Indian Ketorolac Exporters: Complete Supplier Ranking with Market Share — 638 Manufacturers (2026) — TransData Nexus

Q: Who is the largest ketorolac buyer importing from India?

EVERSANA LIFE SCIENCE SERVICES (UNITED STATES) is the largest ketorolac importer from India with a 22.4% market share and import value of $26.0M.

Q: How many ketorolac buyers import from India?

There are 638 active ketorolac buyers importing from India, with a combined import market of $115.9M across 2,961 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top ketorolac buyers from India?

The top 5 ketorolac buyers — EVERSANA LIFE SCIENCE SERVICES, AO "RANBAXY", AO RANBAXY, BAXTER HEALTHCARE CORPORATION, J KNIPPER COMPANY — together control 54.4% of total ketorolac import value from India.

Suresh Sormare

Ketorolac

India Pharmaceutical Trade Intelligence

$115.9M351 Suppliers124 CountriesHS 30049067

ExportsIndia → UNITED STATES63.1%India → RUSSIA23.4%

ImportsUNITED STATES → India$722.1K UNITED KINGDOM → India$13.4K

#1 Supplier: GLAND PHARMA #1 Buyer: EVERSANA LIFE

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $73.2M through 613 shipments. This represents a market share of 63.1% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• EVERSANA LIFE SCIENCE SERVICES - $26.0M (35.5% of country's total business)

• BAXTER HEALTHCARE CORPORATION - $6.6M (9.0% of country's total business)

• J KNIPPER COMPANY - $5.5M (7.6% of country's total business)

• ALMAJECT INC - $4.5M (6.1% of country's total business)

• ALMAJECT - $3.9M (5.4% of country's total business)

• Rest of United States's importers - $26.7M (36.4% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $119.3K, indicating premium pricing strategy compared to the market average of $39.1K.

United States is a key market for Ketorolac imports, representing 63.1% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Ketorolac buyer market intelligence

1Buyer Segment Analysis

The importers of Ketorolac from India can be categorized into several key segments:

1. Distributors: Entities such as EVERSANA LIFE SCIENCE SERVICES and J. KNIPPER & COMPANY in the United States fall into this category. These organizations purchase Ketorolac in bulk to supply to various healthcare providers, pharmacies, and hospitals. Their buying behavior typically involves large-volume orders with a focus on maintaining a consistent supply chain to meet market demand.

2. Contract Manufacturers: Companies like BAXTER HEALTHCARE CORPORATION in the United States are contract manufacturers. They procure Ketorolac as an active pharmaceutical ingredient (API) to produce finished dosage forms under contract for other pharmaceutical companies. Their procurement patterns are aligned with production schedules and contractual obligations, often involving substantial quantities to ensure production efficiency.

3. Re-exporters: Entities such as AO "RANBAXY" in Russia serve as re-exporters. They import Ketorolac from India, possibly for further processing or repackaging, and then export the finished products to other markets. Their purchasing behavior is influenced by both domestic demand and the requirements of their export destinations, leading to variable order sizes and frequencies.

Each segment exhibits distinct procurement behaviors: distributors focus on steady supply to meet ongoing demand, contract manufacturers align purchases with production cycles, and re-exporters adjust orders based on both domestic and international market needs.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Country-Specific Import Regulations

TransData Nexus Ketorolac buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the import regulations for Ketorolac are as follows:

1. United States:

Regulatory Authority: Food and Drug Administration (FDA).

Import Registration Process: Importers must ensure that Ketorolac is FDA-approved. The process involves submitting a New Drug Application (NDA) or an Abbreviated New Drug Application (ANDA) for generic versions.

Estimated Timeline: The approval process can take several months to over a year, depending on the completeness of the application and FDA review times.

Import Tariff/Duty: Pharmaceutical products under HS Code 30049067 are generally duty-free in the United States.

2. Russia:

Regulatory Authority: Ministry of Health of the Russian Federation.

Import Registration Process: Requires state registration of the medicinal product, including submission of a dossier with clinical trial data, quality control methods, and labeling information.

Demand Drivers & Market Opportunity

TransData Nexus Ketorolac buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Ketorolac in importing countries is driven by several factors:

1. Disease Prevalence: Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) used for short-term management of moderate to severe pain. The prevalence of conditions requiring pain management, such as post-operative pain and musculoskeletal disorders, contributes to its demand.

2. Government Healthcare Programs: Many countries have government-funded healthcare programs that include pain management medications. For instance, the inclusion of Ketorolac in national formularies ensures its availability in public healthcare facilities.

3. Universal Health Coverage Expansion: As countries expand their healthcare coverage, access to essential medicines like Ketorolac increases. This expansion leads to higher procurement volumes to meet the needs of a larger patient population.

4. WHO Essential Medicines List Procurement: Ketorolac is listed on the World Health Organization's Model List of Essential Medicines, indicating its importance in a basic health system. This listing encourages countries to procure and stock Ketorolac to meet essential healthcare needs.

5. Tender-Based Purchasing: Many governments and large healthcare providers procure medicines through tender systems to ensure cost-effectiveness and supply reliability. The competitive nature of tenders can lead to increased demand for Ketorolac from suppliers who can meet quality and price criteria.

With 638 buyers across 124 countries, the global market for Ketorolac demonstrates significant demand, influenced by the factors mentioned above.

TransData Nexus Research · Government and regulatory sources

Common Questions — Ketorolac Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest ketorolac buyer importing from India?

Based on import volume and value, EVERSANA LIFE SCIENCE SERVICES (UNITED STATES) leads with $26.0M in imports and a 22.4% market share — the highest of any single ketorolac importer. AO "RANBAXY" (RUSSIA) and AO RANBAXY (RUSSIA) are the next largest buyers.

QHow many companies buy ketorolac from India?

There are 638 active ketorolac buyers importing from India, with a combined market of $115.9M across 2,961 shipments to 124 countries. The top 5 buyers hold 54.4% of total import value, while the remaining 633 buyers handle the other 45.6%.

QWhich countries import the most ketorolac from India?

The top importing countries for ketorolac from India are United States (63.1%), Russia (23.4%), Canada (2.7%), Ecuador (2.0%), United Arab Emirates (0.9%). These markets represent the largest demand centres for Indian pharmaceutical exports of ketorolac, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for ketorolac from India?

The average import transaction value for ketorolac from India is $39.1K, with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Ketorolac buyer market intelligence

1Buyer Segment Analysis

The importers of Ketorolac from India can be categorized into several key segments:

TransData Nexus Research · Government and regulatory sourcesMar 2026

Country-Specific Import Regulations

TransData Nexus Ketorolac buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the import regulations for Ketorolac are as follows:

1. United States:

Regulatory Authority: Food and Drug Administration (FDA).

Estimated Timeline: The approval process can take several months to over a year, depending on the completeness of the application and FDA review times.

Import Tariff/Duty: Pharmaceutical products under HS Code 30049067 are generally duty-free in the United States.

2. Russia:

Regulatory Authority: Ministry of Health of the Russian Federation.

Import Registration Process: Requires state registration of the medicinal product, including submission of a dossier with clinical trial data, quality control methods, and labeling information.

Demand Drivers & Market Opportunity

TransData Nexus Ketorolac buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Ketorolac in importing countries is driven by several factors:

With 638 buyers across 124 countries, the global market for Ketorolac demonstrates significant demand, influenced by the factors mentioned above.

TransData Nexus Research · Government and regulatory sources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Ketorolac

Ketorolac

Who Buys Ketorolac from India — 638 Importers Behind a $115.9M Market

Top Ketorolac Importers — Ranked by Import Value

Top Ketorolac Buyers & Importers

Related Analysis

Need Details?

Ketorolac — Export Intelligence Video

Market Analysis: Top Importing Countries & Importers

Which companies are buying Ketorolac — and from which countries?

Ketorolac — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Ketorolac Buyers & Importers

QWho is the largest ketorolac buyer importing from India?

QHow many companies buy ketorolac from India?

QWhich countries import the most ketorolac from India?

QWhat is the average import order value for ketorolac from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

2Russia

3Canada

4Ecuador

5United Arab Emirates

Analysis Methodology